Brief: Inventiva's Cash Position At End December At 113.0 Million Euros

Inventiva SA

12/02/2021 10:18

Feb 12 (Reuters) - INVENTIVA SA  IVAA.PA :
    * FY REVENUE EUR 0.4 MLN VS EUR 7.0 MLN YR AGO 
    * AT END DECEMBER CASH POSITION EUR 113.0 MLN VS EUR 35.8
MLN YR
AGO   
    * SUCCESSFUL EUR 94.4 MLN IPO LAUNCH ON NASDAQ GLOBAL MARKET
EXTENDS COMPANY'S CASH RUNWAY THROUGH TO Q4 2022 
    * COMPLETION OF ABBVIE’S ONGOING PHASE I CLINICAL TRIAL WITH
ABBV-157 IN PSORIASIS PATIENTS EXPECTED IN Q1 2021 
    * INITIATION OF NATIVE3 PHASE III CLINICAL TRIAL EVALUATING
LANIFIBRANOR IN NASH PLANNED FOR FIRST HALF OF 2021
    * PUBLICATION OF PHASE II CLINICAL TRIAL RESULTS EVALUATING
LANIFIBRANOR IN TYPE 2 DIABETES PATIENTS (T2DM) WITH
NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) EXPECTED IN 2021 

    
    
 Source text source for Eikon:  urn:newsml:reuters.com:*:nGNXbh66wY
    
 Further company coverage:  IVAA.PA ,  ABBV.N 
   


 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00))